Optimizing Durability in Radiofrequency Ablation of Atrial Fibrillation

J Innov Card Rhythm Manag. 2021 May 15;12(5):4507-4518. doi: 10.19102/icrm.2021.120505. eCollection 2021 May.

Abstract

Radiofrequency ablation (RFA) remains a highly effective therapy in the management of paroxysmal atrial fibrillation (PAF) and is an important therapeutic option in the management of persistent atrial fibrillation (PeAF) when clinically indicated. Lesion size is influenced by many parameters, which include those related to energy application (RFA power, temperature, and time), delivery mechanism (electrode size, orientation, and contact force), and the environment (blood flow and local tissue contact, stability, and local impedance). Successful durable RFA is dependent on achieving lesions that are reliably transmural and contiguous, whilst also avoiding injury to the surrounding structures. This review focuses on the variables that can be adjusted in connection with RFA to achieve long-lasting lesions that enable patients to derive the maximum sustained benefit from pulmonary vein isolation and additional lesion sets if utilized.

Keywords: Atrial fibrillation; lesion durability; radiofrequency ablation.